Acurx Pharmaceuticals, Inc. (ACXP)

NASDAQ: ACXP · Real-Time Price · USD

1.260

-0.045 (-3.45%)

At close: Sep 30, 2026, 4:00 PM EDT

1.280

+0.020 (1.59%)

After-hours: Sep 30, 2026, 7:55 PM EDT

Acurx Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	7	6	14	53	46	44
Market Cap Growth	1.65%	-57.48%	-73.92%	14.29%	4.51%	-
Enterprise Value	-4	-0	8	46	36	30
Last Close Price	1.30	2.49	16.28	76.60	79.60	86.43

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PB Ratio	0.75	1.11	22.35	11.30	6.31	3.56
P/TBV Ratio	0.81	1.11	22.35	11.30	6.31	3.56

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Debt / Equity Ratio	-1.31	-1.43	-6.03	-1.60	-1.25	-1.04
Quick Ratio	3.80	3.14	1.16	2.50	4.42	15.36
Current Ratio	3.88	3.18	1.19	2.53	4.55	15.71
Return on Equity (ROE)	-128.11%	-270.80%	-534.03%	-243.33%	-122.61%	-168.71%
Return on Assets (ROA)	-55.92%	-87.59%	-152.62%	-106.65%	-66.79%	-97.21%
Return on Capital Employed (ROCE)	-94.10%	-153.60%	-2296.00%	-312.40%	-165.30%	-103.30%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-113.70%	-136.25%	-102.56%	-27.64%	-26.21%	-28.88%
Buyback Yield / Dilution	-179.63%	-85.46%	-27.56%	-17.15%	-26.72%	-37.88%

SEC Filings: 10-K · 10-Q